Repetitive Transcranial Magnetic Stimulation (rTMS) in the Treatment of Obsessive Compulsive Disorder
Key facts
- Who runs it
- Shanghai Mental Health Center
- Where
- China1 site in 1 countryChoose a country to see its sites
- Trial code
- Status
- Completed
- People taking part
- 53 people enrolled
- Started
- 15 Jul 2019
- Ended
- 30 Sept 2024
- Type of study
- Interventional, 4 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- Continuous theta burst stimulation (cTBS)
- shame rTMS
- Record updated
- 25 May 2025
Who can take part
- Age
- 18 years and older
- Sex
- Women and men
- Healthy volunteers
- Cannot take part
The registry criteria, word for word
Show all 13 criteriaShow less
Who can take part
- age>18 years old
- DSM-5 criteria for OCD
- Y-BOCS total score > or = 16, despite treatment with an adequate trial of a serotonin reuptake inhibitor (SRI) and currently using adequate, stable dose of SRI at least 4 weeks. An adequate SRI trial is defined as treatment for at least 12 weeks on the SRI, that meets or exceeds the recommended dosage level for OCD
- >or=9 yrs education
Who cannot take part
- current use of any investigational drug
- any additional current psychiatric comorbidity, except for obsessive-compulsive personality disorder
- the inability to receive rTMS because of metallic implants, or history of seizures,or history of head injury, or history of neurosurgery
- any major medical disease
- history of long-time use of benzodiazepines
- serious suicide risk
- pregnancy or nursing of an infant
- participation in current clinical study
- TMS/DBS treatment at any point in their lifetime
This trial has no sites in United States.
It has sites in one country. Choose a country to see its sites.
About the trial
What the trial wants to find out
This study will evaluate the possible therapeutic effects of repetitive transcranial magnetic stimulation(rTMS) in obsessive-compulsive disorder (OCD) in OCD patients who have not fully responded to pharmacotherapy, and the underlying neural mechanism by EEG.
The 4 groups in the trial
- Group1: rTMS(bilateral SMA)Existing treatment, for comparison
Continuous theta burst stimulation (cTBS) stimulation will be applied over the bilateral SMA once a day, 5 days/week, for 4 weeks.
Treatment: Continuous theta burst stimulation (cTBS)
- Group2: rTMS(right DLPFC)Treatment being tested
Continuous theta burst stimulation (cTBS) stimulation will be applied over the right DLPFC once a day, 5 days/week, for 4 weeks.
Treatment: Continuous theta burst stimulation (cTBS)
- Group3: rTMS(right DLPFC+bilateral SMA)Treatment being tested
Continuous theta burst stimulation (cTBS) stimulation will be applied over the right DLPFC and bilateral SMA once a day, 5 days/week, for 4 weeks.
Treatment: Continuous theta burst stimulation (cTBS)
- Group4: shame rTMSSham treatment, for comparison
The sham rTMS will be applied over the bilateral SMA once a day, 5 days/week, for 4 weeks.
Treatment: shame rTMS
Saves a reminder to your own calendar to look at this page again. Frontlight sends no messages and does not know you set it.
Data and sources
- Registry record
- Listed on ClinicalTrials.gov.How to verify a trial in the registry
- Official title
- A Randomized Clinical Trial of Repetitive Transcranial Magnetic Stimulation (rTMS) Treatment for Obsessive-Compulsive Disorder
- Record updated
- 25 May 2025